We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNN icon
3701
Denison Mines
DNN
$2.92B
$12K ﹤0.01%
10,409
+10,053
+2,824% +$11.9K
ECC
3702
Eagle Point Credit Company
ECC
$510M
$12K ﹤0.01%
1,141
-1,702
-60% -$18.5K
EML icon
3703
Eastern Company
EML
$153M
$12K ﹤0.01%
+629
New +$13.1K
EMLP icon
3704
First Trust North American Energy Infrastructure Fund
EMLP
$4.19B
$12K ﹤0.01%
+452
New +$12K
FATBB
3705
DELISTED
FAT Brands
FATBB
$12K ﹤0.01%
3,671
-937
-20% -$3.92K
FBNC icon
3706
First Bancorp
FBNC
$2.74B
$12K ﹤0.01%
267
-6,489
-96% -$284K
FLUX icon
3707
Flux Power
FLUX
$12.7M
$12K ﹤0.01%
3,126
+473
+18% +$1.91K
FORA
3708
DELISTED
Forian
FORA
$12K ﹤0.01%
+4,237
New +$12.9K
GIPR icon
3709
Generation Income Properties
GIPR
$514K
$12K ﹤0.01%
254
+118
+87% +$5.97K
GLP icon
3710
Global Partners
GLP
$1.72B
$12K ﹤0.01%
344
-11,186
-97% -$346K
GNPX icon
3711
Genprex
GNPX
$2.18M
0
GXC icon
3712
State Street SPDR S&P China ETF
GXC
$470M
$12K ﹤0.01%
156
+144
+1,200% +$10.4K
HFBL icon
3713
Home Federal Bancorp
HFBL
$73M
$12K ﹤0.01%
717
-68
-9% -$1.25K
HMC icon
3714
Honda
HMC
$41B
$12K ﹤0.01%
501
+402
+406% +$9.31K
HRTX icon
3715
Heron Therapeutics
HRTX
$63.9M
$12K ﹤0.01%
4,809
-66,361
-93% -$214K
ICHR icon
3716
Ichor Holdings
ICHR
$2.66B
$12K ﹤0.01%
461
-3,828
-89% -$102K
IMNN icon
3717
Imunon
IMNN
$6.93M
$12K ﹤0.01%
733
+119
+19% +$2.29K
INFA
3718
DELISTED
Informatica
INFA
$12K ﹤0.01%
776
-54
-7% -$969
IPAY icon
3719
Amplify Mobile Payments ETF
IPAY
$188M
$12K ﹤0.01%
314
-1
-0.3% -$40
KAVL
3720
DELISTED
Kaival Brands Innovations Group
KAVL
$12K ﹤0.01%
612
+380
+164% +$8.4K
KT icon
3721
KT
KT
$9.11B
$12K ﹤0.01%
884
+804
+1,005% +$10.7K
LBTYK icon
3722
Liberty Global Class C
LBTYK
$3.49B
$12K ﹤0.01%
625
-19,421
-97% -$367K
LEXX icon
3723
Lexaria Bioscience
LEXX
$14.9M
$12K ﹤0.01%
335
+93
+38% +$3.34K
LXRX icon
3724
Lexicon Pharmaceuticals
LXRX
$1.03B
$12K ﹤0.01%
6,324
-13,065
-67% -$27.8K
MGPI icon
3725
MGP Ingredients
MGPI
$379M
$12K ﹤0.01%
120
-452
-79% -$50.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.